Publications
Carmen BURTEA
Open the Institutional Repository
Number of publications : 264
2024
Scientific congresses and symposiums/Poster
  • Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (June 2024). "Selection of peptides for a muscle-targeted delivery of ASOs directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo" [Poster presentation]. 31th Annual FSHD Society International Research Congress, Denver, United States - Colorado.
  • Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (April 2024). "Selection of peptides for a muscle-targeted delivery of ASOs directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo" [Poster presentation]. 8th International congress Myology, Paris, France.
Scientific conferences in universities or research centers/Scientific conference in universities or research centers
  • Kahvecioglu, Z. C., Samuel Vandecasteele, Marine Bougard, Sarah Peeters, Laurent, S., Saussez, S., & Burtea, C. (17 October 2024). "Novel approaches in targeted drug delivery systems based on engineered peptides for the treatment of anaplastic thyroid cancer" [Paper presentation]. Journée scientifique de la Société Royale de Chimie "Bioinspired Chemistry: from Molecules to Cells", Mons, Belgium.
  • Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Sarah Peeters, Daubry, A., Laurent, S., Saussez, S., & Burtea, C. (06 February 2024). "Toward the development of a novel drug using engineered peptides designed for EGFR-mediated drug delivery of an apoptosis inducer in anaplastic thyroid carcinoma" [Paper presentation]. Télévie Seminar.
Top
2023
Scientific journals/Article
  • Andre, S., Verteneuil, S., Ris, L., Kahvecioglu, Z. C., Nonclercq, D., De winter, J., Vander elst, L., Laurent, S., Muller, R., & Burtea, C. (29 December 2023). Modulation of Cytosolic Phospholipase A2 as a Potential Therapeutic Strategy for Alzheimer’s Disease. "Journal of Alzheimer's Disease Reports, 7" (1), 1395-1426. doi:10.3233/adr-230075
  • BOUTRY, S., LAURENT, S., & BURTEA, C. (2023). Editorial for: "Treatment Response Assessment in Multiple Myeloma: Histogram Analysis of Total Tumor Apparent Diffusion Coefficient based on Whole-body Diffusion-weighted MR Imaging". "Journal of Magnetic Resonance Imaging". doi:10.1002/jmri.29158
  • Balas, M., Predoi, D., Burtea, C., & Dinischiotu, A. (07 February 2023). New Insights into the Biological Response Triggered by Dextran-Coated Maghemite Nanoparticles in Pancreatic Cancer Cells and Their Potential for Theranostic Applications. "International Journal of Molecular Sciences, 24" (4), 3307. doi:10.3390/ijms24043307
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Limpens, M., Derenne, A., Burtea, C., Laurent, S., Legrand, A., Wilton, S., Belayew, A., Coppée, F., Decleves, A.-E., & Tassin, A. (2023). "Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo" [Paper presentation]. Physphar Spring meeting (2023), Brussels, Belgium.
Scientific congresses and symposiums/Poster
  • Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Peeters, S., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (24 November 2023). "Innovative drug delivery system using EGFR-targeted engineered peptides in anaplastic thyroid cancer treatment" [Poster presentation]. PhD Day SFMBBM 2023, Liège, Belgium.
  • Kahvecioglu, Z. C., Vandecasteele, S., Bougard, M., Rogien, C., Daubry, A., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (27 October 2023). "Novel therapeutic approaches for EGFR-mediated drug delivery using engineered peptides in anaplastic thyroid cancer" [Poster presentation]. Annual BACR Meeting 2023 Friday October 27th, CIRCADIAN CYCLE, CHRONOBIOLOGY AND CANCER, brussels, Belgium.
  • Kahvecioglu, Z. C., Samuel Vandecasteele, Marine Bougard, Charlotte Rogien, Journe, F., Laurent, S., Saussez, S., & Burtea, C. (02 July 2023). "Development of a novel EGFR-targeted peptide for targeted delivery of drugs in anaplastic thyroid cancer" [Poster presentation]. PBA 2023 33rd International Symposium on Pharmaceutical and Biomedical Analysis, ankara, Turkey.
  • M. Limpens, Derenne, A., Burtea, C., Laurent, S., A. Legrand, S. Wilton, A. Belayew, F. Coppée, A-E. Declèves, & A. Tassin. (2023). "Selection of peptides for a muscle-targeted delivery of ASO directed against DUX4 mRNAs through complementary approaches in silico, in vitro and in vivo" [Poster presentation]. FSH Society, Milan, Italy.
Scientific conferences in universities or research centers/Scientific conference in universities or research centers
  • Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Rogien, C., Vandecasteele, S., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (02 February 2023). "A study of combined targeted therapy and delivery, inducing an inhibition of PI3K/AKT/mTOR pathway in anaplastic thyroid cancer cells" [Paper presentation]. 2023 Télévie Seminar, bruxelles, Belgium.
Top
2022
Scientific journals/Article
Scientific congresses and symposiums/Poster
  • Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Rogien, C., Vandecasteele, S., Rogien, C., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (11 September 2022). "Novel therapeutic strategy targeting the EGFR and inhibiting PI3K/AKT/mTOR pathway in anaplastic thyroid carcinoma" [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis, Mons, Belgium.
  • Tchéoubi, E. S. R., Akpovi, C. D., Coppée, F., Tassin, A., Decleves, A.-E., Fiogbé, S. E., Sègbo, G. J., Laurent, S., & Burtea, C. (11 September 2022). "PCSK9 variants affect differently the risk of type 2 diabetes mellitus development. Potential impact on the therapy with PCSK9 inhibitors" [Poster presentation]. 12th International Symposium on Drug Analysis & 32nd International Symposium on Pharmaceutical and Biomedical Analysis.
  • LIMPENS, M., Derenne, A., Burtea, C., Legrand, A., Decleves, A.-E., Coppée, F., & Tassin, A. (17 June 2022). "Towards a muscle-targeted delivery of antisense agents against DUX4" [Poster presentation]. The 29th FSHD Society's annual International Research Congress 2022.
  • Kahvecioglu, Z. C., Toulehohoun, A., Feudjio Tagny, D., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (08 April 2022). "PI3K/AKT/mTOR pathway inhibition and targeted drug delivery combined in a novel therapeutic strategy addressed to anaplastic thyroid carcinoma" [Poster presentation]. Séminaire Télévie.
Dissertations and theses/Master’s dissertation
Top
2021
Scientific congresses and symposiums/Unpublished conference/Abstract
  • TCHEOUBI, S. E. R.* , AKPOVI, C. D., Coppée, F., Decleves, A.-E., FIOGBE, S. E., Sègbo, G. J., AGBANGLA, C., Laurent, S., & Burtea, C. (06 September 2021). "PCSK9 intronic variant rs142149050 is associated with low level of LDL-cholesterol and lower cardiovascular risk in type 2 diabetes" [Paper presentation]. - 4ème Congrès international de la Société Africaine de Physiologie et Physiopathologie (SA2P), Cotonou, Benin.
Scientific congresses and symposiums/Poster
  • Kahvecioglu, Z. C.* , Bruynbroeck, M., Gheysen, L., Journé, F., Laurent, S., Saussez, S., & Burtea, C.*. (22 September 2021). "Delivery of a drug molecule to thyroid cancer cells via EGFR targeting" [Poster presentation]. 'Adaptation of the tumour and its ecosystem to radiotherapies' workshop ,September 22nd-25th, 2021, Manoir de Kerdréan, Le Bono, France.
  • Kahvecioglu, Z. C., Gheysen, L., Journe, F., Laurent, S., Saussez, S., & Burtea, C. (21 May 2021). "Toward the development of peptide inhibitors targeted to PI3K/AKT signalling pathway for the therapy of anaplastic thyroid carcinoma" [Poster presentation]. 27th Porto Cancer meeting Stemness & Metastasis: Advances in Research and Clinical Translation, Porto, Portugal.
Patents/Patent
  • Burtea, C., Laurent, S., & ANDRE, S. (17 June 2021). "PEPTIDES BINDING TO LDL-RECEPTOR AS CARRIERS FOR CROSSING THE BLOOD BRAIN BARRIER".
Top
2020
Scientific journals/Article
  • Crombez, D., Delcambre, S., Nonclercq, D., Vander Elst, L., Laurent, S., Cnop, M., Muller, R., & Burtea, C. (15 August 2020). Modulation of Adiponectin Receptors AdipoR1 and AdipoR2 by Phage Display-Derived Peptides in in vitro and in vivo Models. "Journal of Drug Targeting, 28" (7-8), 831-851. doi:10.1080/1061186X.2019.1710840
  • Popescu Din, I. M., Balas, M., Hermenean, A., Vander Elst, L., Laurent, S., Burtea, C., Cinteza, L. O., & Dinischiotu, A. (2020). Novel Polymeric Micelles-Coated Magnetic Nanoparticles for In Vivo Bioimaging of Liver: Toxicological Profile and Contrast Enhancement. "Materials".
  • Andre, S., Larbanoix, L., Verteneuil, S., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (05 June 2020). Development of an LDL receptor-targeted peptide susceptible to facilitate the brain access of diagnostic or therapeutic agents. "Biology, 9, 161", 1-26. doi:10.3390/biology9070161
  • Canei, J., Burtea, C., & Nonclercq, D. (17 April 2020). Comparative study of the visual system of two psammophilic lizards (Scincus scincus & Eumeces schneideri). "Vision Research, 171", 17-30.
  • Fanfone, D., Stanicki, D., Nonclercq, D., Port, M., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (14 March 2020). Molecular Imaging of Galectin-1 Expression as a Biomarker of Papillary Thyroid Cancer by Using Peptide-Functionalized Imaging Probes. "Biology, 9" (53), 1-25. doi:10.3390/biology9030053
Books/Collective work published as editor or director
  • Burtea, C., Saussez, S., Port, M., Burtea, C. (Ed.), Saussez, S. (Ed.), & Port, M. (Ed.). (2020). "Molecular Targets and Targeting in Biomedical Sciences". MDPI Basel.
Scientific congresses and symposiums/Unpublished conference/Abstract
Scientific congresses and symposiums/Poster
  • Burtea, C., & Laurent, S. (27 January 2020). "Nouvelle approche de ciblage moléculaire dans le domaine de la santé" [Poster presentation]. Evénement de maillage UMONS-CHU Ambrise Paré (UMHAP), Mons, Mons, Belgium.
  • Tchéoubi, E. R. S., AKPOVI, C. D., & Burtea, C. (27 January 2020). "Effets des mutations de la PCSK9 sur le profil lipidique et l'adiponectine chez les patients diabétiques au Bénin" [Poster presentation]. Evénement de maillage UMONS-CHU Ambrise Paré (UMHAP), Mons, Mons, Belgium.
Top
2019
Scientific congresses and symposiums/Unpublished conference/Abstract
  • TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., AGBANGLA, C., & Burtea, C. (16 September 2019). "PCSK9 synonymous variant gln342=, insulin and adiponectin levels in type 2 diabetes mellitus patients" [Paper presentation]. VIIème Colloques des sciences, cultures et technologies, Campus universitaire d'Abomey-Calavi, Benin.
  • TCHEOUBI, S. E. R., AKPOVI, C. D., FIOGBE, S. E., KOUGNIMON, F. E., SEGBO, J. A., SAGBO, G. G., Burtea, C., & AGBANGLA, C. (21 June 2019). "Gestational diabetes mellitus is associated with a decrease in calcium and glucose levels in newborn" [Paper presentation]. 2ème Journées Africaines d'Endocrinologie clinique, Abidjan, Côte d’Ivoire.
  • TCHEOUBI, S. E. R., AKPOVI, C. D., Coppée, F., Decleves, A.-E., Laurent, S., & Burtea, C. (21 June 2019). "Linking PCSK9 genetic variants with insulin impairment in type 2 diabetes mellitus patients" [Paper presentation]. 2ème Journées Africaines d'Endocrinologie clinique, Abidjan, Côte d’Ivoire.
Scientific congresses and symposiums/Poster
  • Andre, S., Atakana Lukulu, J. M., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (28 October 2019). "A promising phospholipase A2 targeted peptide slowing amyloid beta pathology in an Alzheimer's disease mouse model" [Poster presentation]. the 2nd International Conference on Neurovascular and Neurodegenerative Diseases, Paris, France.
  • Andre, S., Atakana Lukulu, J. M., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (24 May 2019). "Development of an original phospholipase A2-targeted peptide able to reduce amyloid pathology in a mouse model of Alzheimer's disease" [Poster presentation]. 13th National Congress of the Belgian Society for Neuroscience, Brussels, Belgium. doi:10.3389/conf.fnins.2019.96.00032
  • TCHEOUBI, S. E. R., Coppée, F., Decleves, A.-E., Laurent, S., AKPOVI, C. D., & Burtea, C. (17 May 2019). "PCSK9 gene variants in west - African type 2 diabetes mellitus (T2DM) patients" [Poster presentation]. Ecole doctorale EDT-BCMB (Biologie Cellulaire et Moléculaire & Biochimie - FNRS), Bruxelles, ULB - Campus Erasme, Belgium.
  • TCHEOUBI, S. E. R., Andre, S., Laurent, S., & Burtea, C. (18 March 2019). "Nouvelle Approche de Ciblage Moléculaire dans le Domaine de la Santé" [Poster presentation]. Evénement de maillage UMONS-CHU Ambroise Paré (UMHAP), Mons, Belgium.
  • Derenne, A., Kouakou, C., Belayew, A., Decleves, A.-E., Tassin, A., Burtea, C., & Coppée, F. (08 March 2019). "Development of peptides for specific skeletal muscle targeted drug delivery" [Poster presentation]. 2019 Advances in Skeletal Muscle Biology in Health and Disease, University of Florida, United States - Florida.
  • TCHEOUBI, S. E. R., AKPOVI, C. D., & Burtea, C. (05 March 2019). "Effets des mutations PCSK9 sur le profil lipidique et l'adiponectine chez les patients atteints de diabète de type 2 au Bénin" [Poster presentation]. Mardi des Chercheurs, Mons, Belgium.
Patents/Patent
Top
2018
Scientific journals/Article
  • Demine, S., Balhuizen, A., Debaille, V., Joosten, L., Fereau, M., Chilla, S. N. M., Millard, I., Scharfmann, R., Egrise, D., Goldman, S., Marchetti, P., Gotthardt, M., Laurent, S., Burtea, C., & Eizirik, D. (21 August 2018). Imaging of Human Insulin Secreting Cells with Gd-DOTA-P88, a Paramagnetic Contrast Agent Targeting the Beta Cell Biomarker FXYD2 gamma-a. "Molecules, 23" (9), 2100. doi:10.3390/molecules23092100
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Andre, S., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (07 July 2018). "Phospholipase A2 targeting for the development of an original therapeutic strategy in the context of Alzheimer's disease" [Paper presentation]. 11th FENS Forum of Neuroscience, Berlin, Germany.
Scientific congresses and symposiums/Poster
  • Andre, S., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (28 February 2018). "Therapy of Alzheimer's disease: inhibitory potential of a phospholipase A2-targeted peptide able to cross the blood-brain barrier" [Poster presentation]. Belgian peptide Group Meeting, Bruxelles, Belgium.
Dissertations and theses/Doctoral thesis
  • Rinchon, A. (2018). "Etude des effets de la neuroinflammation développée au cours de l'encéphalomyélite autoimmune expérimentale sur l'hippocampe de la souris" [Doctoral thesis, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/21161
Patents/Patent
  • Burtea, C., Crombez, D., & Laurent, S. (24 December 2018). "PEPTIDE AGONISTS OF ADIPONECTIN RECEPTORS 1 AND 2".
Top
2017
Scientific journals/Article
  • Andre, S., Ansciaux, E., Saidi, E., Larbanoix, L., Stanicki, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (07 November 2017). Validation by magnetic resonance imaging of the diagnostic potential of a heptapeptide-functionalized imaging probe targeted to amyloid beta and able to cross the blood-brain barrier. "Journal of Alzheimer's Disease, 60" (4), 1547-1565. doi:10.3233/JAD-170563
  • Fanfone, D., Despretz, N., Stanicki, D., Rubio Magnieto, J., Fossepre, M., Surin, M., Rorive, S., Salmon, I., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (2017). Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1. "Medical Oncology".
  • Balas, M., Ciobanu, C. S., Burtea, C., Stan, M. S., Bezirtzoglou, E., Predoi, D., & Dinischiotu, A. (21 February 2017). Characterization, and Toxicity Evaluation of Dextran - Coated Iron Oxide Nanoparticles. "Metals, 7" (2), 63-80. doi:10.3390/met7020063
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Derenne, A., Tassin, A., Burtea, C., Decleves, A.-E., & Coppée, F. (13 September 2017). "Development of specific molecules using the phage display technology allowing a targeted drug delivery to skeletal muscles in the aim to treat muscular disorders.»" [Paper presentation]. Journée PhD day EDT en Sciences Pharmaceutiques, Liège, Belgium.
  • Andre, S., Daldal, F., Delcroix, M., Verteneuil, S., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (16 May 2017). "Blood-brain barrier crossing for improving brain access using a peptide able to bind a receptor-mediated transcytosis" [Paper presentation]. BMIC, Bruxelles, Belgium.
  • Fanfone, D., Paternoster, Q., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (16 March 2017). "Imaging of papillary thyroid cancer using peptide vectorized iron oxide nanoparticles targeted to galectin-1" [Paper presentation]. 3rd Belgium Molecular Imaging Congress, Bruxelles, Belgium.
Scientific congresses and symposiums/Poster
  • Andre, S., Daldal, F., Lecomte, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (22 May 2017). "The phospholipase A2 signaling as a new therapeutic biomarker of Alzheimer's disease: modulation through phage display-derived peptides able to cross the blood-brain barrier" [Poster presentation]. 12th Meeting of the Belgian Neutoscience Society, Ghent, Belgium. doi:10.3389/conf.fnins.2017.94.00057
  • Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (10 April 2017). "Towards the therapy of Alzheimer's disease via the inhibition of a phospholipase A2 isoform using peptides able to cross the blood-brain barrier" [Poster presentation]. BNA 2017 : festival of neuroscience, Birmingham, United Kingdom.
  • Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (07 March 2017). "Targeting phospholipase A2 for the treatment of Alzheimer's disease through a peptidic modulation" [Poster presentation]. MDC : Mardi des Chercheurs 2017, Mons, Belgium.
  • Fanfone, D., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (07 March 2017). "Development of peptide vectorized contrast agents targeting galectin-1 in the context of imaging diagnosis of papillary thyroid cancer" [Poster presentation]. Mardi des Chercheurs (MdC2017), Mons, Belgium.
Patents/Patent
  • Burtea, C., Laurent, S., Muller, R., Stanicki, D., Fanfone, D., & Saussez, S. (26 September 2017). "Galectin-1 binding peptides and use thereof for diagnostic and therapeutic purpose".
Top
2016
Scientific journals/Article
  • Burtea, C., Laurent, S., Sanli, T., Fanfone, D., Devalckeneer, A., Sauvage, S., Beckers, M.-C., Rorive, S., Salmon, I., Vander Elst, L., Lauwerys, B. R., & Muller, R. (10 November 2016). Screening for peptides targeted ti IL-7Ralpha for molecular imaging of rheumatoid arthritis synovium. "Arthritis Research and Therapy, 18" (230). doi:10.1186/s13075-016-1133-8
  • Dentamaro, M., Lux, F., Vander Elst, L., Dauguet, N., Montante, S., Moussaron, A., Burtea, C., Muller, R., Tillement, O., & Laurent, S. (09 June 2016). Chemical and in vitro characterizations of a promising bimodal AGuIX probe able to target apoptotic cells for applications in MRI and optical imaging. "Contrast Media and Molecular Imaging, 11", 381-395. doi:10.1002/cmmi.1702
  • Rossez, Y., Burtea, C., Laurent, S., Gosset, P., Renaud, L., Gonzalez, W., Ballet, S., Raynal, I., Rousseaux, O., Dugué, T., Vander Elst, L., Michalski, J.-C., Muller, R., & Robbe-Masselot, C. (14 January 2016). Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC. "Contrast Media and Molecular Imaging, 11" (3), 211-221. doi:10.1002/cmmi.1682
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Fanfone, D., Stanicki, D., Fossepre, M., Surin, M., Rorive, S., Vander Elst, L., Laurent, S., Muller, R., Saussez, S., & Burtea, C. (08 December 2016). "Papillary thyroid cancer diagnostic by galectin-1 targeting using peptide vectorized contrast agent for MRI" [Paper presentation]. Séminaire des chercheurs Télévie 2017, Woluwé, Belgium.
  • Crombez, D., Muller, R., & Burtea, C. (04 May 2016). "Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism" [Paper presentation]. Diabetes Kongress, Berlin, Germany.
Scientific congresses and symposiums/Poster
  • Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (10 December 2016). "Phospholipase A2 modulation in Alzheimer's disease: new approach of treatment using peptides able to accede to the brain through the LDL receptor" [Poster presentation]. Joint meeting of the Belgian Neurological Society and Belgian Dementia Council (BeDeCo) December 10th 2016, Antwerp, University of Antwerp, Belgium.
  • Andre, S., Ansciaux, E., Larbanoix, L., Fanfone, D., Nonclercq, D., Vander Elst, L., Laurent, S., Muller, R., & Burtea, C. (29 November 2016). "Targeting amyloid plaques for the early diagnosis of Alzheimer's disease: validation of a vectorized superparamagnetic contrast agent able to cross the blood-brain barrier" [Poster presentation]. BMIC 'Imaging in Drug Discovery and development', Janssen Pharmaceutica, Beerse, Belgium.
  • Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (08 October 2016). "New therapeutic management of Alzheimer's disease: interest to a phospholipase A2-targeted peptide able to cross the blood-brain barrier through the LDL receptor" [Poster presentation]. Belgian Brain Congress, MICX. October 8, 2016, Mons, Belgium. doi:10.3389/conf.fnagi.2016.03.00046
  • Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (03 September 2016). "Study of novel galectin-1 targeted peptides in the context of a new and non-invasive papillary thyroid cancer diagnosis and evaluation of their potential inhibitor effect" [Poster presentation]. 39th annual meeting of the european thyroid association, Copenhague, Denmark.
  • Andre, S., Verteneuil, S., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (08 June 2016). "Stratégie thérapeutique de la maladie d'Alzheimer par délivrance ciblée et modulation peptidique d'une phospholipase" [Poster presentation]. 13ème RFMASA Réunion francophone sur la maladie d'Alzheimer et les syndromes apparentés. 8 au 10 juin 2016, Lyon, France.
  • Crombez, D., Vander Elst, L., Muller, R., & Burtea, C. (18 May 2016). "Nouvelle stratégie thérapeutique du diabète de type 2 : activation de la voie AMPK via un agoniste peptidique des récepteurs de l'adiponectine" [Poster presentation]. 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France.
  • Fanfone, D., Stanicki, D., Laurent, S., Rorive, S., Saussez, S., Vander Elst, L., Muller, R., & Burtea, C. (18 May 2016). "Approche diagnostique non invasive du cancer thyroïdien à l'aide de peptides ciblant la galectine-1 à potentiel anti-cancéreux" [Poster presentation]. 9ème édition de la Matinée des Chercheurs 2016 (MdC2016), Valenciennes, France.
  • Andre, S., Daldal, F., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (18 May 2016). "Approche thérapeutique de la maladie d'Alzheimer : passage de la barrière hémato-encéphalique et modulation peptidique d'une phospholipase A2" [Poster presentation]. 9ème édition de la Matinée des Chercheurs 2016 (MdC2016); Mons; Belgique; 2015, Valenciennes, France.
  • Crombez, D., Muller, R., & Burtea, C. (04 May 2016). "Potential therapeutic peptides targeted to adiponectin receptors, able to modulate the AMPK pathway and regulate the glucose and lipid metabolism" [Poster presentation]. Diabetes Kongress, Berlin, Germany.
  • Crombez, D., Muller, R., & Burtea, C. (17 February 2016). "Type 2 diabetes and metabolic syndrome : agonist peptides targeted to adiponectin receptors are new therapeutic strategy by activation of AMPK pathway" [Poster presentation]. Belgian Peptide Group Meeting, Bruxelles, Belgium.
  • Andre, S., Verteneuil, S., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (17 February 2016). "Peptide-mediated modulation of a phospholipase isoform and blood-brain barrier transcytosis in the context of Alzheimer's disease therapy" [Poster presentation]. Belgian Peptide Group Meeting, Bruxelles, Belgium.
  • Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (17 February 2016). "Effects of novel galectin-1-targeted peptides on human cells in the context of a new and non-invasive thyroid cancer diagnosis" [Poster presentation]. Belgian Peptide Group Meeting, Bruxelles, Belgium.
Dissertations and theses/Master’s dissertation
  • Deruche-Lienard, A., Burtea, C., & Laurent, S. (2016). "Diagnostic spécifique du cancer thyroïdien papillaire à l'aide d'un agent de contraste IRM ciblant la galectine-I" [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/4691
Top
2015
Scientific journals/Article
  • Ansciaux, E., Burtea, C., Laurent, S., Crombez, D., Nonclercq, D., Vander Elst, L., & Muller, R. (05 June 2015). In vitro and in vivo characterization of several functionalized USPIO vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. "Contrast Media and Molecular Imaging, 10" (3), 211-224. doi:10.1002/CMMI.1626
  • Ansciaux, E., Burtea, C., Laurent, S., Nonclercq, D., Vander Elst, L., & Muller, R. (2015). In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. "Contrast Media and Molecular Imaging".
  • Burtea, C., Laurent, S., Crombez, D., Delcambre, S., Sermeus, C., Millard, I., Rorive, S., Flamez, D., Beckers, M.-C., Salmon, I., Vander Elst, L., Eizirik, D., & Muller, R. (18 February 2015). Development of a peptide-functionalized imaging nanoprobe for the targeting of (FXYD2)gamma-a as a highly specific biomarker of pancreatic beta cells. "Contrast Media and Molecular Imaging, 10" (5), 398-412. doi:10.1002/cmmi.1641
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Andre, S., Verteneuil, S., Delcroix, M., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (22 May 2015). "Development of a new therapeutic approach for Alzheimer's disease by phospholipase pathway modulation and blood-brain barrier shuttling" [Paper presentation]. 11th National Congress of the Belgian Society for Neuroscience, Mons, Belgium. doi:10.3389/conf.fnins.2015.89.00068
  • Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (22 April 2015). "Well-differentiated thyroid cancer diagnostic imaging: development of a non-invasive method by peptidic targeting of galectin-1" [Paper presentation]. Belgium Molecular Imaging Community Congress, Bruxelles, Belgium.
Scientific congresses and symposiums/Poster
  • Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (11 December 2015). "Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers" [Poster presentation]. Bioforum-bioliege, Liège, Belgium.
  • Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Rorive, S., Vander Elst, L., Saussez, S., & Burtea, C. (03 December 2015). "Development of a galectin-1 targeted contrast agent for the MRI diagnosis of papillary thyroid cancer" [Poster presentation]. Televie's researchers seminar : towards new therapies for cancer patients, Gembloux, Belgium.
  • Fanfone, D., Despretz, N., Stanicki, D., Laurent, S., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (03 October 2015). "Development of a new diagnosis approach by MRI of papillary thyroid cancer using a vectorized contrast agent directed against galectin-1" [Poster presentation]. ESMRMB 2015 32th annual scientific meeting, Edimbourg, United Kingdom.
  • Crombez, D., Scaux, G., Muller, R., & Burtea, C. (22 May 2015). "A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors" [Poster presentation]. Journée d'études UMHAP - from lab to bedside, UMONS, Belgium.
  • Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (22 May 2015). "Galectin-1, a potential molecular imaging biomarker of well-differentiated thyroid cancers" [Poster presentation]. Première Journée d'Etudes UMHAP, Mons, Belgium.
  • Crombez, D., Scaux, G., Muller, R., & Burtea, C. (13 May 2015). "A metabolic therapy of Type 2 Diabetes : AMPK activation by agonist peptides targeted to adiponectin receptors" [Poster presentation]. Bioforum 2015- ULG, Liège, Belgium.
  • Andre, S., Verteneuil, S., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (13 May 2015). "The targeting of phospholipase signaling and of LDL receptor aiming to develop a new therapeutic approach for Alzheimer's disease management" [Poster presentation]. Bioforum 2015- ULG, Liège, Belgium.
  • Andre, S., Verteneuil, S., Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (10 March 2015). "Toward the development of a therapeutic strategy applied to Alzheimer's disease via phospholipase signaling" [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.
  • Crombez, D., Scaux, G., Muller, R., & Burtea, C. (10 March 2015). "Development of an Adiponectin Receptor Agonist for the Metabolic Therapy of Type 2 Diabetes" [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.
  • Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (10 March 2015). "Specific strategy of thyroïd cancer diagnosis by galectin-1 targeting" [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium.
  • Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (31 January 2015). "Toward the development of a galectin-1 targeted imaging probe as a useful tool for the thyroid cancer diagnosis" [Poster presentation]. ABEC-BVSK Annual meeting (BACR), UCL Woluwé, Belgium.
  • Crombez, D., Laurent, S., Scaux, G., Vander Elst, L., Muller, R., & Burtea, C. (16 January 2015). "Development of a molecular approach for the monitoring and treatment of diabetic patients" [Poster presentation]. 7th annual meeting ISMRM Benelux, Ghent, Belgium.
  • Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (16 January 2015). "Thyroid cancer imaging :peptidic targeting of galectin-1 as a diagnostic tool" [Poster presentation]. 7th annual meeting ISMRM Benelux, Ghent, Belgium.
  • Fanfone, D., Despretz, N., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (16 January 2015). "Thyroid cancer imaging :peptidic targeting of galectin-1 as a diagnostic tool" [Poster presentation]. 7th annual meeting ISMRM Benelux, Ghent, Belgium.
Dissertations and theses/Master’s dissertation
  • Methnani, I. (2015). "Influence du substrat sur le comportement cellulaire - Etude de l'endocytose de nanoparticules d'oxyde de fer" [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/16781
  • Methnani, I., Burtea, C., & Laurent, S. (2015). "Influence du substrat sur le comportement cellulaire - Etude de l'endocytose de nanoparticules d'oxyde de fer" [Master’s dissertation, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/16705
Top
2014
Scientific journals/Article
  • Zghikh, L., Vangysel, E., Nonclercq, D., Legrand, A., Blairon, B., Berri, C., Bordeau, T., Rémy, C., Burtea, C., Montuelle, S., & Bels, V. (02 September 2014). Morphology and fiber-type distribution in the tongue of the Pogona vitticeps lizard (Iguania: Agamidae). "Journal of Anatomy, 225 (4)", 377-389.
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Fanfone, D., Despretz, N., Laurent, S., Arcolia, V., Muller, R., Vander Elst, L., Saussez, S., & Burtea, C. (30 November 2014). "Peptidic targeting of galectin-1 as a useful tool in the thyroid cancer diagnosis" [Paper presentation]. EDT-Cancérologie expérimentale:annual mini symposium 'From clinic to lab and vice versa', Liège, Belgium.
  • Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (13 June 2014). "Un agent de contraste vectorisé contre les plaques amyloïdes et potentiellement capable de franchir la barrière hémato-­encéphalique : vers un diagnostic précoce de la maladie d'Alzheimer par imagerie de résonance magnétique" [Paper presentation]. 12ème Réunion Francophone sur la Maladie d'Alzheimer et les syndromes apparentés, Montpellier, France.
Scientific congresses and symposiums/Poster
  • Crombez, D., Scaux, G., Muller, R., & Burtea, C. (18 November 2014). "Thérapie métabolique des troubles liés au diabète de type 2 via le développement d'un agoniste du récepteur de l'adiponectine" [Poster presentation]. Biomarqueurs d'imagerie du métabolisme et du risque cardio-vasculaire, Lyon, France.
  • Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., Nonclercq, D., & Muller, R. (10 February 2014). "A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-­brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging" [Poster presentation]. Belgian Peptide Meeting, Ghent, Belgium.
  • Crombez, D., Delcambre, S., Muller, R., & Burtea, C. (10 February 2014). "Development of a peptide agonist of adiponectin receptor for the therapy of type 2 diabetes and metabolic syndrome" [Poster presentation]. Belgian Peptide Meeting, Ghent, Belgium.
Top
2013
Scientific journals/Article
  • Mao, H., Chen, W., Laurent, S., Thirifays, C., Burtea, C., Rezaee, F., & Mahmoudi, M. (24 July 2013). Hard Corona Composition and Cellular Toxicities of the Graphene Sheets. "Colloids and Surfaces B: Biointerfaces, 109", 212-218.
  • Laurent, S., Ng, E.-P., Thirifays, C., Lakiss, L., Goupil, J., Mintova, S., Burtea, C., Oveisi, E., Hebert, C., Vries, M., Motazacker, M., Rezaee, F., & Mahmoudi, M. (25 April 2013). Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions. "Toxicology Research, 2", 270-279.
  • Laurent, S., Burtea, C., Thirifays, C., Rezaee, F., & Mahmoudi, M. (15 February 2013). Significance of cell ''observer' and protein source in nanobiosciences. "Journal of Colloid and Interface Science, 392", 431.
  • Sclavons, C., Burtea, C., Boutry, S., Laurent, S., Vander Elst, L., & Muller, R. (04 February 2013). Phage display screening for tumor necrosis factor-alpha-binding peptides. Detection of inflammation in a mouse model of hepatitis. "International Journal of Peptides, 2013", 9. doi:10.1155/2013/348409
  • Laurent, S., Ng, E., Thirifays, C., Lakiss, L., Goupil, J., Mintova, S., Burtea, C., Oveisi, E., Hebert, C., Vries, M., Motazacker, M., Rezaee, F., & Mahmoudi, M. (2013). Corona protein composition and cytotoxicity evaluation of ultrasmall zeolites synthesized from template free precursor suspensions. "Toxicology Research".
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Radu, M., Burtea, C., Predoi, D., Muller, R., & Dinischiotu, A. (06 July 2013). "Toxicological aspects of PANC -1 cells exposure to iron oxide dextran - coated nanoparticles" [Paper presentation]. The 38th FEBS Congress, Saint Petersburg, Russia.
  • Radu, M., Burtea, C., Predoi, D., & Muller, R. (06 July 2013). "Toxicological aspects of PANC-1 cells exposure to iron oxide dextran-covered nanoparticles" [Paper presentation]. The 38th FEBS Congress, Saint Petersburg, Russia.
  • Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (28 May 2013). "The design of nanoparticles for molecular imaging: a multidisciplinary task" [Paper presentation]. E-MRS 2013 SPRING MEETING, SPRING 13 U: Design of multifunctional nano-objects for biomedical applications, Strasbourg, France.
  • Muller, R., Vander Elst, L., Laurent, S., & Burtea, C. (27 May 2013). "The design of nanoparticles for molecular imaging: a multidisciplinary task" [Paper presentation]. E-MRS 2013 SPRING MEETING, SPRING 13 U: Design of multifunctional nano-objects for biomedical applications, Strasbourg, France.
  • Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (26 May 2013). "A contrast agent vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging" [Paper presentation]. 8th Annual Meeting of the European Society of Molecular Imaging, Torino, Italy.
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (26 May 2013). "Development of molecular imaging tools for the monitoring of diabetic patients" [Paper presentation]. 8th Annual Meeting of the European Society of Molecular Imaging, Torino, Italy.
  • den Adel, B., Suidgeest, E., Burtea, C., Stammes, M. A., van der Heiden, K., Laurent, S., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (24 May 2013). "E-selectin targeted MRI visualizes progression of atherosclerotic plaques" [Paper presentation]. 8th annual meeting of the European Society for Molecular Imaging, ESMI, Turin, Italy.
  • den Adel, B., Suidgeest, E., Burtea, C., van der Heiden, K., Stammes, M. A., Laurent, S., Gijsen, F., Muller, R., Poelmann, R. E., & Van der Weerd, L. M. (24 May 2013). "Vascular cell adhesion molecule-1 targeted nanoparticles discriminate between atherosclerotic plaque stages in disease progression and therapy" [Paper presentation]. 8th annual meeting of the European Society for Molecular Imaging, ESMI, Turin, Italy.
  • den Adel, B., Suidgeest, E., Burtea, C., Stammes, M. A., van der Heiden, K., Laurent, S., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (20 April 2013). "E-selectin targeted USPIO enhancement of atherosclerotic plaques visualizes treatment response and mechanism of action" [Paper presentation]. 21ème congrès de l'ISMRM, Salt Lake City, United States - Utah.
  • Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (06 March 2013). "Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging" [Paper presentation]. International Congress Alzheimer's Disease/Parkinson's Disease 2013, Florence, Italy.
Scientific congresses and symposiums/Poster
  • Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (24 May 2013). "USPIO-PHO: a new vectorized contrast agent for early Diagnosis of Alzheimer's disease By molecular imaging" [Poster presentation]. 1st Health Institute Day, Mons, Belgium.
  • Crombez, D., Burtea, C., & Muller, R. (24 May 2013). "Therapy of type 2 diabetes: development of an agonist of adiponectin receptor" [Poster presentation]. 1st Health Institute Day, Mons, Belgium.
  • Ansciaux, E., Burtea, C., Nonclercq, D., Vander Elst, L., Laurent, S., & Muller, R. (29 January 2013). "Alzheimer's disease : new promising vectorized contrast agents for early diagnosis and evaluation of future therapeutic strategies using magnetic resonance imaging" [Poster presentation]. Journée Scientifique des Doctorants en Sciences biomédicales et pharmaceutiques; New tools and strategies in the identification of pathology-related biomarkers, Mons, Belgium.
Top
2012
Scientific journals/Article
  • Mahmoudi, M., Saeedi-Eslami, S.-E., Shokrgozar, M. A., Azadmanesh, K., Hasanloo, M., Kalhor, H., Burtea, C., Rothen-Rutishauser, B., Laurent, S., Sheibani, S., & Vali, H. (03 December 2012). Cell 'vision': complementary factor of protein corona in nanotoxicology. "Nanoscale, 4" (17), 5461-5468.
  • Verwilst, P., Eliseeva, S., Vander Elst, L., Burtea, C., Laurent, S., Petoud, S., Muller, R., Parac-Vogt, T. N., & De Borggraeve, W. M. (04 June 2012). A Tripodal Ruthenium-Gadolinium Metallostar as a Potential a(v)ß(3) Integrin Specific Bimodal Imaging Contrast Agent. "Inorganic Chemistry, 51" (11), 6405-6411. doi:10.1021/ic300717m
  • Burtea, C., Ballet, S., Laurent, S., Rousseaux, O., Dencausse, A., Gonzalez, W., Port, M., Corot, C., Vander Elst, L., & Muller, R. (19 April 2012). Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis targeted ultrasmall superparamagnetic iron oxide derivatives. "Arteriosclerosis, Thrombosis, and Vascular Biology, 32" (6), 36-48.
  • Arsalani, N., Fattahi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (04 February 2012). Polyglycerol-grafted superparamagnetic iron oxide nanoparticles: highly efficient MRI contrast agent for liver and kidney imaging and potential scaffold for cellular and molecular imaging. "Contrast Media and Molecular Imaging, 7", 185-194.
  • Laurent, S., Burtea, C., Thirifays, C., Häfeli, U. O., & Mahmoudi, M. (10 January 2012). The Importance of toxicity assay modifications and 'Cell Vision'. "PLoS ONE, 7" (1), 29997. doi:10.1371/journal.pone.0029997
Scientific congresses and symposiums/Poster
  • den Adel, B., Burtea, C., Laurent, S., Suidgeest, E., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (30 November 2012). "Stageing of atherosclerotic plaques by a vascular cell adhesion protein-1 targeted contrast agent" [Poster presentation]. Fourth annual meeting of the ISMRM Benelux, Leuven, Belgium.
  • denAdel, B., Burtea, C., Suidgeest, E., Laurent, S., Poelmann, R. E., Muller, R., & van der Weerd, L. (05 September 2012). "Molecular MRI of Atherosclerosis and Anti-Atherosclerotic Therapy Outcome by a Vascular Cell Adhesion Molecule-1 Targeted Contrast Agent" [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland.
  • denAdel, B., Burtea, C., Laurent, S., Suidgeest, E., Poelmann, R. E., Muller, R., & van der Weerd, L. (05 September 2012). "Imaging Anti-Atherosclerotic Therapy Response and macrophage polarization in ApoE-/- Mice Using E-selectin Targeted USPIOs" [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland.
  • Ansciaux, E., Burtea, C., Vander Elst, L., Laurent, S., & Muller, R. (17 June 2012). "Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer" [Poster presentation]. Doctoriales Franco-Belges, Mont Saint-Aubert, Belgium.
  • Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (22 May 2012). "Développement de nouveaux agents de contraste vectorisés destinés au diagnostic par IRM de la maladie d'Alzheimer" [Poster presentation]. 11ème Réunion sur la Maladie d'Alzheimer et les Symptomes Apparentés, Toulouse, France.
Learning materials/Course notes
  • Burtea, C. (2012). "Biologie, y compris les éléments de génétique humaine, Syllabus".
Patents/Patent
  • Muller, R., Eizirik, D., Sermeus, C., Laurent, S., Burtea, C., Beckers, M.-C., & Flamez, D. (27 December 2012). "Molecules specifically binding pancreatic beta cells biomarkers".
  • Burtea, C., Laurent, S., Muller, R., Sermeus, C., & Eizirik, D. (26 December 2012). "Molecules specifically binding pancreatic beta cells biomarkers".
Top
2011
Scientific journals/Article
  • Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 July 2011). Synthesis and characterization of new low-molecular-weight lysine-conjugated Gd-DTPA contrast agents. "Contrast Media and Molecular Imaging, 6" (4), 229-235. doi:10.1002/cmmi.422
  • Larbanoix, L., Burtea, C., Ansciaux, E., Laurent, S., Mahieu, I., Vander Elst, L., & Muller, R. (01 June 2011). Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. "Peptides, 32" (6), 1232-43. doi:10.1016/j.peptides.2011.04.026
  • Kiyofuji, K., Tsunekawa, K., Yamashita, M., Yamashita, J., Fujie, M., Asai, K., Suyama, T., Ito, S., Reddy, V. K., Yamada, M., Ogawa, K., Ozaki, N., Sugiyama, M., Yamaoka, M., Makita, R., Nakamura, S., Aoki, T., Yu, G., Aoshima, K., ... Muller, R. (01 January 2011). Preparation and Evaluation of Novel Sugar Dendritic Gd-DTPA Complexes for MRI Contrast Agents and Phospha Sugars for Anti-tumour Agents. "Advanced Materials Research, 222", 217-220. doi:10.4028/www.scientific.net/AMR.222.217
  • VERWILST, P., ELISEEVA, S. V., CARRON, S., Vander Elst, L., Burtea, C., Dehaen, G., Laurent, S., Binnemans, K., Muller, R., Parac-Vogt, T. N., & De Borggraeve, W. M. (2011). A modular approach towards the synthesis of target-specific MRI contras agents. "European Journal of Inorganic Chemistry", 3577-3585. doi:10.1002/ejic.201100575
Scientific congresses and symposiums/Unpublished conference/Abstract
  • den Adel, B., Burtea, C., Laurent, S., Stammes, M. A., Suidgeest, E., Poelmann, R. E., Muller, R., & Van der Weerd, L. M. (19 June 2011). "Molecular MR imaging of atherosclerotic plaques by a vascular cell adhesion protein-1 targeted contrast agent" [Paper presentation]. 6th European Molecular Imaging Meeting, ENIM, Leiden, Netherlands.
Scientific congresses and symposiums/Poster
  • Burtea, C., Laurent, S., Lancelot, E., Rousseaux, O., Ballet, S., Thirifays, C., Port, M., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (22 November 2011). "Development and validation of a peptide-vectorized superparamagnetic imaging probe designed for the detection of inflammation in atherosclerotic plaque" [Poster presentation]. 4ème Journée Scientifique du Pôle Hainuyer 'Arts et Sciences', HEH, Mons, Belgium.
  • Ansciaux, E., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 October 2011). "In vitro and in vivo characterization of several functionalized USPIO derivatives designed for molecular MRI of Alzheimer's disease" [Poster presentation]. 28th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Leipzig, Germany.
  • Fattahi, H., Arsalani, N., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (05 September 2011). "Preparation of novel polyglycerol-iron oxide hybrid nanoparticles as high efficient MRI contrast agent for liver and kidney imaging" [Poster presentation]. IUPAC 9th International Conference on Advanced Polymers Via Macromolecular Engineering, Cappadocia, Turkey.
  • Rossez, Y., Laurent, S., Burtea, C., Gossez, P., Mouray, A., Chassat, T., Dugué, T., Rousseaux, O., Gonzalez, W., Ballet, S., Raynal, I., Muller, R., Michalski, J.-C., & Robbe-Masselot, C. (09 July 2011). "Identification of peptidic ligands targeting MUC5AC for the development of contrast products adapted to the magnetic resonance imaging of human colon cancer" [Poster presentation]. 11th International Workshop on Carcinoma-associated Mucins, Robinson College, Cambridge, United Kingdom.
  • Ansciaux, E. A., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (19 June 2011). "Biological characterization of several functionalized USPIO derivatives designed for the molecular MRI of Alzheimer's disease" [Poster presentation]. 6th European Molecular Imaging Meeting, ENIM, Leiden, Netherlands.
  • Sclavons, C., Burtea, C., Boutry, S., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (07 April 2011). "Targeting of inflammation with a phage-display targeting peptide" [Poster presentation]. Biomedica, Eindhoven, Netherlands.
Patents/Patent
  • Burtea, C., Laurent, S., Muller, R., Sermeus, C., & Eizirik, D. (23 June 2011). "Molecules specifically binding pancreatic beta cells biomarkers".
Top
2010
Scientific journals/Article
  • Burtea, C., Laurent, S., Mahieu, I., Larbanoix, L., Roch, A., Port, M., Rousseaux, O., Ballet, S., Murariu, O., Toubeau, G., Corot, C., Vander Elst, L., & Muller, R. (29 December 2010). In vitro biomedical applications of functionalized iron oxide nanoparticles, including those not related to magnetic properties. "Contrast Media and Molecular Imaging, 6" (4), 236-50. doi:10.1002/cmmi.423
  • Larbanoix, L., Burtea, C., Laurent, S., Van Leuven, F., Toubeau, G., Vander Elst, L., & Muller, R. (31 October 2010). Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease. "Neurobiology of Aging, 31" (10), 1679-89. doi:10.1016/j.neurobiolaging.2008.09.021
  • Rerat, V., Laurent, S., Burtea, C., Driesschaert, B., Pourcelle, V., Vander Elst, L., Muller, R., & Marchand-Brynaert, J. (15 March 2010). Ultrasmall particle of iron oxide - RGD peptidomimetic conjugate: synthesis and characterization. "Bioorganic and Medicinal Chemistry Letters, 20" (6), 1861-1865. doi:10.1016/j.bmcl.2010.01.150
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Yamashita, M., Ozaki, N., Yamashita, J., Fujie, M., Sugiyama, M., Ogawa, K., Aoki, T., Ito, S., Reddy, V. K., Yamada, M., Aoshima, K., Kamikage, N., Ravi Sankar, A. U., Yu, G., Kiyofuji, K., Takehara, Y., Sakahara, H., Takayanagi, H., Laurent, S., ... Muller, R. (19 May 2010). "Researches on sugar modified dendritic Gd-DTPA complexes for MRI contrast agents" [Paper presentation]. Contrast-enhanced biomedical imaging, 12th Bi-Annual Conference on Contrast Agents and Multimodal Molecular Imaging, Mons, Belgium.
  • Burtea, C., Laurent, S., Ballet, S., Port, M., Rousseaux, O., Thirifays, C., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (19 May 2010). "Development of a robust protocol for vulnerable plaque characterization by using two peptide-functionalized USPIO derivaties" [Paper presentation]. Contrast-enhanced biomedical imaging, 12th Bi-Annual Conference on Contrast Agents and Multimodal Molecular Imaging, Mons, Belgium.
Scientific congresses and symposiums/Poster
  • Sclavons, C., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (19 May 2010). "MRI targeting of apoptotic cells in injured areas of brain in a mouse model of Parkinson's disease" [Poster presentation]. Contrast-enhanced biomedical imaging, 12th Bi-Annual Conference on Contrast Agents and Multimodal Molecular Imaging, Mons, Belgium.
  • Laurent, S., Burtea, C., Rerat, V., Marchand, J., Vander Elst, L., & Muller, R. (01 May 2010). "Ultrasmall particle of iron oxide - RGD peptidomimetic conjugate as novel MRI contrast agent" [Poster presentation]. ISMRM, Stockholm, Sweden.
  • Burtea, C., Laurent, S., Lancelot, E., Rousseaux, O., Ballet, S., Thirifays, C., Port, M., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (01 May 2010). "Development and validation of a peptide-vectorized superparamagnetic imaging probe designed for detection of inflammation in atherosclerotic plaque" [Poster presentation]. ISMRM, Stockholm, Sweden.
Top
2009
Scientific journals/Article
  • Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Rousseaux, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (2009). Molecular MRI of VCAM-1 expression in inflammatory lesions by using a peptide-vectorized paramagnetic imaging probe. "Journal of Medicinal Chemistry".
  • Burtea, C., Laurent, S., Lancelot, E., Ballet, S., Muriariu, O., Rousseaux, O., Port, M., Vander Elst, L., Corot, C., & Muller, R. (2009). Identification of Peptide Ligands that Target Apoptotic Cells by Means of Specific Interactions with Phosphatidylserine. Applications to Molecular Imaging by MRI. "Molecular Pharmaceutics".
  • Boutry, S., Forge, D., Burtea, C., Mahieu, I., Murariu, O., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2009). How to quantify iron in an aqueous or biological matrix: a technical note. "Contrast Media and Molecular Imaging, 4" (6), 299-203. doi:10.1002/cmmi.291
  • Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Rousseaux, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (01 January 2009). Magnetic Resonance Molecular Imaging of Vascular Cell Adhesion Molecule-1 Expression in Inflammatory Lesions Using a Peptide-Vectorized Paramagnetic Imaging Probe. "Journal of Medicinal Chemistry, 52" (15), 4725-4742. doi:10.1021/jm9002654
  • Yamashita, J., Yamashita, M., Fujie, M., Suyama, K. A. T., Ito, S., Reddy, V. K., Yamada, M., Ogawa, K., Ozaki, N., Nakamura, S., Aoki, T., Yu, G., Aoshima, K., Kato, T., Kamikage, N., Kiyofuji, K., Takehara, Y., Sakahara, H., Takayanagi, H., ... Muller, R. (01 January 2009). R&D of novel medicinal materials for curing cancer: sugar modified Gd-DTPA MRI contrast agents and Phospha Sugar Anti-cancer agents. "Journal of Automation, Mobile Robotics and Intelligent Systems, 3" (4), 80-83.
  • Burtea, C., Laurent, S., Lancelot, E., Ballet, S., Murariu, O., Rousseaux, O., Port, M., Vander Elst, L., Corot, C., & Muller, R. (01 January 2009). Peptidic Targeting of Phosphatidylserine for the MRI Detection of Apoptosis in Atherosclerotic Plaques. "Molecular Pharmaceutics, 6" (6), 1903-1919. doi:10.1021/mp900106m
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Burtea, C., Laurent, S., Lancelot, E., Port, M., Ballet, S., Rousseaux, O., Vander Elst, L., & Muller, R. (30 May 2009). "Molecular MRI of apoptosis in atherosclerotic plaque by using a peptide-vectorized paramagnetic imaging probe" [Paper presentation]. 4th European Molecular Imaging Meeting, Barcelone, Spain.
Scientific congresses and symposiums/Poster
  • Larbanoix, L., Burtea, C., Laurent, S., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (28 May 2009). "Recherche par phage display et caractérisation de peptides ciblant les plaques amyloïdes de la maladie d'Alzheimer" [Poster presentation]. 23ème journées franco-belges de pharmacochimie, 'de la conception à la réalisation en pharmacochimie', Université de Mons, Belgium.
  • Larbanoix, L., Burtea, C., Laurent, S., Van Leuven, F., Toubeau, G., Vander Elst, L., & Muller, R. (01 April 2009). "Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease" [Poster presentation]. Biomedica, Liège, Belgium.
  • Sclavons, C., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (01 April 2009). "MRI targeting of apoptotic cells in injured areas of brain in a mouse model of Parkinson's disease" [Poster presentation]. Biomedica, Liège, Belgium.
Diverse speeches and writings/Article for a general audience
  • Laurent, S., Burtea, C., & Boutry, S. (2009). "L'imagerie moléculaire, un nouvel outil multidisciplinaire de la recherche biomédicale".
Top
2008
Parts of books/Contribution to collective works
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (2008). Contrast Agents: magnetic resonance. In "Molecular Imaging I" (pp. 135-165). Springer. doi:10.1007/978-3-540-72718-7_7
Scientific journals/Article
  • Burtea, C., Laurent, S., Murariu, O., Rattat, D., Toubeau, G., Verbruggen, A., Vansthertem, D., Vander Elst, L., & Muller, R. (01 January 2008). Molecular imaging of alpha(v)beta(3) integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA. "Cardiovascular Research, 78" (1), 148-157. doi:10.1093/cvr/cvm115
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Burtea, C., & Muller, R. (27 September 2008). "Imagerie de l'athérosclérose par IRM" [Paper presentation]. IVe Symposium « Lipides et Athérosclérose », Charleroi, Belgium.
  • Aoki, T., Yamashita, M., Ogawa, K., Ozaki, N., Fujie, M., Sugiyama, M., Aoshima, K., Mizuno, S., Kamikage, N., Yamashita, J., Yu, G., Krishna Reddy, V., Oshikawa, T., Takehara, Y., Sakahara, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (21 September 2008). "Synthesis and evaluation of chemically-modified novel MRI contrast agents with sugars" [Paper presentation]. 11th Bratisvlava Symposium on Saccharides, Smolenice Castle, Slovakia.
  • Yamashita, M., Aoki, T., Ito, S., Ogawa, K., Ozaki, N., Fujie, M., Yu, G., Aoshima, K., Sugiyama, M., Kamikage, N., Yamashita, J., Takehara, Y., Sakahara, H., Takayanagi, H., Oshikawa, T., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (21 September 2008). "Research on cancer finding and chemotherapy at the early stage - syntheses and evaluations of novel sugar-ball-dendrimer MRI contrast agents and pgospha sugars by sugar modification" [Paper presentation]. 11th Bratisvlava Symposium on Saccharides, Smolenice Castle, Slovakia.
  • Burtea, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Murariu, O., Toubeau, G., Vander Elst, L., Corot, C., & Muller, R. (10 September 2008). "Molecular imaging of VCAM-1 expression in inflammatory pathologies by using low-molecular weight peptides conjugated to a paramagnetic reporter" [Paper presentation]. World Molecular Imaging Congress, Nice, France.
Scientific congresses and symposiums/Poster
  • Larbanoix, L., Burtea, C., Laurent, S., Van Leuven, F., Toubeau, G., Vander Elst, L., & Muller, R. (10 September 2008). "Potential amyloid plaque-specific peptides for the diagnosis of Alzheimer's disease" [Poster presentation]. World Molecular Imaging Congress, Nice, France.
  • Sclavons, C., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (07 September 2008). "MRI targeting of apoptotic cells in injured areas of brain in a mouse model of Parkinson's disease" [Poster presentation]. World Molecular Imaging Congress, Nice, France.
  • Yamashita, M., Aoki, T., Ogawa, K., Ozaki, N., Fujie, M., Yamashita, J., Aoshima, K., Kamikage, N., Yu, G., Oshikawa, T., Takehara, Y., Sakahara, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (03 July 2008). "Construction of DDS of Gd-DTPA Complex with Sugar Ball Dendrimer for Drawing Blood Vessels and Tumors by MRI" [Poster presentation]. International Conference on Organometallic Chemistry, Rennes, France.
  • Sclavons, C., Burtea, C., Laurent, S., Murariu, O., Toubeau, G., Vander Elst, L., & Muller, R. (01 January 2008). "Ciblage IRM de l'apoptose dans les zones lésées dans la maladie de Parkinson" [Poster presentation]. Congrès du GRAMM, Lyon, France.
Patents/Patent
  • Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). "Compounds for the diagnosis of diseases associated with VCAM expression".
  • Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). "Compounds for diagnosing apoptosis".
  • Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). "Compounds for the diagnosis of diseases associated with VCAM expression".
  • Port, M., Rousseaux, O., Muller, R., & Burtea, C. (23 October 2008). "Compounds for diagnosing apoptosis".
Top
2007
Scientific journals/Article
  • Yu, G., Yamashita, M., Aoshima, K., Kobayashi, M., Kato, T., Kamikage, N., Takahashi, M., Takayanagi, H., Oshikawa, T., Laurent, S., Burtea, C., Vander Elst, L., Muller, R., Takehara, Y., & Sakahara, H. (01 January 2007). Studies on preparation and characterization of novel MRI contrast agents for targeting organs and blood vessels. "Heterocyclic Communications, 13" (2-3), 101-108.
  • Segers, J., Laumonier, C., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2007). From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. "Bioconjugate Chemistry, 18" (4), 1251-1258. doi:10.1021/bc060377f
  • Yu, G., Yamashita, M., Aoshima, K., Takahashi, M., Oshikawa, T., Takayanagi, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 January 2007). A glycosylated complex of gadolinium, a new potential contrast agent for magnetic resonance angiography? "Bioorganic and Medicinal Chemistry Letters, 17" (8), 2246-2249. doi:10.1016/j.bmcl.2007.01.067
Scientific congresses and symposiums/Poster
  • Burtea, C., Corot, C., Laurent, S., Port, M., Lancelot, E., Ballet, S., Vander Elst, L., & Muller, R. (14 June 2007). "Research of phage display-selected peptides with specific affinity for Vascular Cell Adhesion Molecule-1 (VCAM-1) overexpressed in atherosclerotic plaques" [Poster presentation]. International Conference of the European Society of Molecular Imaging, Naples, Italy.
  • Ogawa, K., Ozaki, N., Fujie, M., Yamashita, M., Yu, G., Aoshima, K., Kobayashi, M., Kato, T., Kamikage, N., Aoki, T., Takayanagi, H., Oshikawa, T., Takehara, Y., Sakahara, H., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 January 2007). "Studies on novel MRI contrast agents for specific organs, blood vessels, and tumors" [Poster presentation]. 14th European Carbohydrate Symposium - Eurocarb 14, Lubeck, Germany.
  • Larbanoix, L., Burtea, C., Laurent, S., Murariu, O., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (01 January 2007). "In vitro characterization of Ab42 specific heptapeptides selected by phage display and preliminary studies on Alzheimer's disease diagnosis by MRI with peptide functionalized contrast agents" [Poster presentation]. European Society for molecular imaging, Second International Conference, (ESMI), Naples, Italy.
Top
2006
Scientific journals/Article
  • Parac-Vogt, T. N., Vander Elst, L., Kimpe, K., Laurent, S., Burtea, C., Chen, F., Vand Deun, R., Ni, Y. C., Muller, R., & Binnemans, K. (01 January 2006). Pharmacokinetic and in vivo evaluation of a self-assembled gadolinium(III)-iron(II) contrast agent with high relaxivity. "Contrast Media and Molecular Imaging, 1" (6), 267-278. doi:10.1002/cmmi.114
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Yamashita, M., Ito, S., Hu, G., Fujie, M., Taishi, N., Sakata, Y., Ogawa, K., Ozaki, N., Kasthuraiah, M., Ogawa, T., Otake, Y., Asai, K., Aoki, S., Hara, Y., Aoshima, K., Kobayashi, M., Kamikage, N., Takahashi, M., Takayanagi, H., ... Muller, R. (25 September 2006). "Some recent approaches towards innovation of cancer therapy. Improvement of QOL of patients and novel materials for early stage findings and madical treatments for tumors by collaboration of medical sciences and engineering" [Paper presentation]. 5th International Conference on Global Research and Education, Iasi, Romania.
Scientific congresses and symposiums/Poster
  • Yamashita, M., Ito, S., Hu, G., Fujé, M., Taishi, N., Sakara, Y., Ogawa, K., Kasthuraiah, M., Ogawa, T., Otake, Y., Asai, S., Aoki, S., Hara, Y., Aoshima, K., Kobayashi, M., Kamikage, N., Takahashi, M., Takayanagi, H., Oshikawa, T., ... Muller, R. (10 December 2006). "Some recent approaches towards innovation of cancer therapy. Improvement of QOL of patients and novel materials for early stage findings and madical treatments for tumors by collaboration of medical sciences and engineering" [Poster presentation]. The 5th International Conference on Global Research and Education, Proceedings, Iasi, Romania.
  • Larbanoix, L., Burtea, C., Laurent, S., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 September 2006). "In vitro characterization of an A-beta-42 specific heptapeptide selected by phage display and preliminary MRI evaluation of Alzheimer's disease detection by functionalized USPIO" [Poster presentation]. Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Varsovie, Poland.
  • Burtea, C., Laurent, S., Vander Elst, L., Toubeau, G., & Muller, R. (15 September 2006). "Molecular imaging of angiogenic blood vessels in vulnerable atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA" [Poster presentation]. Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Varsovie, Poland.
  • Burtea, C., Laurent, S., Vander Elst, L., Toubeau, G., & Muller, R. (15 May 2006). "Molecular imaging of angiogenic blood vessels in vulnerable atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA" [Poster presentation]. Opening Life Science Facilities, Philips Research Europe, Eindhoven, Netherlands.
  • Larbanoix, L., Burtea, C., Laurent, S., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 May 2006). "Identifications par phage display et caractérisations in vitro d'heptapeptides ciblant le peptide amyloïde A-beta-42 qui permettront la détection par imagerie moléculaire des plaques séniles de la maladie d'Alzheimer" [Poster presentation]. Journées franco-belges de Pharmacochimie, Lille, France.
Top
2005
Scientific journals/Article
  • Parac-Vogt, T. N., Kimpe, K., Laurent, S., Vander Elst, L., Burtea, C., Chen, F., Muller, R., Ni, Y. C., Verbruggen, A., & Binnemans, K. (01 January 2005). Synthesis, characterization, and pharmacokinetic evaluation of a potential MRI contrast agent containing two paramagnetic centers with albumin binding affinity. "Chemistry, 11" (10), 3077-3086. doi:10.1002/chem.200401207
  • Burtea, C., Laurent, S., Roch, A., Vander Elst, L., & Muller, R. (01 January 2005). C-MALISA (cellular magnetic-linked immunosorbent assay), a new application of cellular ELISA for MRI. "Journal of Inorganic Biochemistry, 99" (5), 1135-1144. doi:10.1016/j.jinorgbio.2005.02.009
  • Boutry, S., Burtea, C., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (01 January 2005). Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent. "Magnetic Resonance in Medicine, 53" (4), 800-807. doi:10.1002/mrm.20403
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Laumonier, C., Segers, J., Burtea, C., Vander Elst, L., & Muller, R. (29 October 2005). "Selecting vectors to image apoptosis by phage display technique" [Paper presentation]. Contrast Media Research Symposium, San Diego, United States - California.
  • Burtea, C., Larbanoix, L., Laurent, S., Toubeau, G., Vander Elst, L., & Muller, R. (01 October 2005). "Phage display screening for peptides that specifically target the amyloid peptide A-beta1-42 for molecular imaging of the senile plaques in Alzheimer disease" [Paper presentation]. Contrast Media Research Symposium, Evian, France.
  • Larbanoix, L., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (20 September 2005). "Research of peptides with specific affinity for the amyloid peptide A-beta1-42 by phage display for the MRI detection of amyloid plaques in Alzheimer disease" [Paper presentation]. Annual Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Basel, Switzerland.
  • Laurent, S., Burtea, C., Vander Elst, L., Yamamoto, T., Shimokawa, H., Katayama, Y., & Muller, R. (15 September 2005). "Gd-EB-DTPA, a new dye-based MRI contrast agent" [Paper presentation]. Annual Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Basel, Switzerland.
  • Laurent, S., Burtea, C., Larbanoix, L., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 September 2005). "Preliminary investigations on the synthesis, physicochemical and biological characterization of a new stilbene derivative grafted to USPIO dedicated to MRI diagnosis of Alzheimer disease" [Paper presentation]. Annual Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Basel, Switzerland.
  • Yamashita, M., Aoshima, K., Kobayashi, M., Kato, T., Kamikage, N., Takahashi, M., Takayanagi, H., Oshikawa, T., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (21 August 2005). "Studies on novel MRI contrast agents for targeting organs and blood vessels" [Paper presentation]. 13th European Carbohydrate symposium, Bratislava, Slovakia.
Scientific congresses and symposiums/Poster
  • Burtea, C., Larbanoix, L., Laurent, S., Vander Elst, L., & Muller, R. (15 September 2005). "Synthèse et caractérisation physico-chimique et biologique d'un agent de contraste vectorisé par un dérivé du stilbène destiné au diagnostic par IRM de la maladie d'Alzheimer" [Poster presentation]. Symposium on structure-based drug design (SRC), Mons, Belgium.
  • Larbanoix, L., Burtea, C., Laurent, S., Murariu, O., Vansthertem, D., Toubeau, G., Van Leuven, F., Vander Elst, L., & Muller, R. (15 June 2005). "In vitro characterization of A-beta-42 specific heptapeptides selected by phage display and preliminary studies on Alzheimer's disease diagnosis by MRI with peptide-functionalized contrast agents" [Poster presentation]. International Conference of the European Society of Molecular Imaging, Naples, Italy.
  • Burtea, C., Laurent, S., Chaabane, L., Canet Soulas, E., Vander Elst, L., & Muller, R. (30 May 2005). "Molecular targeting of angiogenic blood vessels in atherosclerotic plaques with a new low molecular weight non-peptidic RGD mimetic" [Poster presentation]. Proceedings of the International Society for Magnetic Resonance in Medicine, Miami, United States - Florida.
  • Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (30 May 2005). "Synthesis and characterisation of new low molecular weight lysine-conjugated Gd-DTPA contrast agents suited for MR angiography" [Poster presentation]. Proceedings of the International Society for Magnetic Resonance in Medicine, Miami, United States - Florida.
  • Segers, J., Laumonier, C., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (30 May 2005). "Stealthy magnetophages, a new tool for molecular imaging" [Poster presentation]. Proceedings of the International Society for Magnetic Resonance in Medicine, Miami, United States - Florida.
  • Burtea, C., Laurent, S., Murariu, O., Larbanoix, L., Vander Elst, L., & Muller, R. (15 May 2005). "A novel relaxometric method for the measurement of biochemical reactions based on functionalized magnetic nanoparticles" [Poster presentation]. Nanowal (Wallonia Network for Nanotechnologies), Mons, Belgium.
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (15 May 2005). "New perspectives in magnetic resonance molecular imaging" [Poster presentation]. Nanowal (Wallonia Network for Nanotechnologies), Mons, Belgium.
Top
2004
Scientific journals/Article
  • Gossuin, Y., Burtea, C., Monseux, A., Toubeau, G., Roch, A., Muller, R., & Gillis, P. (11 May 2004). Ferritin-induced relaxation in tissues: An in vitro study. "Journal of Magnetic Resonance Imaging, 20" (4), 690-697. doi:10.1002/jmri.20152
Scientific congresses and symposiums/Poster
  • Burtea, C., Laurent, S., Roch, A., Vander Elst, L., & Muller, R. (10 December 2004). "Streptavidin-based magnetic nanosensors as an useful tool in clinical diagnosis" [Poster presentation]. Chemistry and self-assembly for nanotechnology, FUNDP, Namur, Belgium.
  • Kimpe, K., Laurent, S., Vogt, T., Burtea, C., Henrotte, V., Vander Elst, L., Binnemans, K., & Muller, R. (01 January 2004). "A novel efficient MRI contrast agent containing two paramagnetic centra" [Poster presentation]. ISMRM, Kyoto, Japan.
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2004). "C-MALISA (Cellular Magneted-Linked Immunosorbent Assay) as a new strategy in molecular MRI" [Poster presentation]. AMI annual meeting, Orlando, United States - Florida.
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2004). "Preclinical evaluation of several Integrin-targeted contrast agents" [Poster presentation]. 21th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Copenhague, Denmark.
  • Yamashita, M., Laurent, S., Burtea, C., Vander Elst, L., & Muller, R. (01 January 2004). "A new glycosylated complex of gadolinium, a new potential contrast agent for MR angiography ?" [Poster presentation]. ISMRM, Kyoto, Japan.
  • Burtea, C., Laurent, S., Roch, A., Vander Elst, L., & Muller, R. (01 January 2004). "Highly sensitive Streptavidin-based magnetic nanosensors as an useful tool in clinical diagnosis" [Poster presentation]. 21th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Copenhague, Denmark.
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2004). "Development of molecular contrast agents for MRI" [Poster presentation]. Cost B12, Radiotracers for in vivo assessment of biological function, 7th Cost B12 WG3 meeting, Radiolabeled biologically active peptides, Ljubljana, Slovenia.
  • Burtea, C., Chaabane, L., Laurent, S., Canet Soulas, E., Vander Elst, L., Briguet, A., & Muller, R. (01 January 2004). "Preclinical evaluation of a new alpha(v)-beta(3)-targeted nonpeptidic RGD mimetic grafted to USPIO. Preliminary investigations on the molecular imaging of vulnerable atherosclerotic plaques" [Poster presentation]. 21th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Copenhague, Denmark.
Top
2003
Scientific journals/Article
  • Burtea, C., Laurent, S., Colet, J.-M., Vander Elst, L., & Muller, R. (01 January 2003). Development of new glucosylated derivatives of Gd-DTPA for MRI angiography. "Investigative Radiology, 38" ((6)), 320-333. doi:10.1097/01.RLI.0000066251.65982.e6
Scientific congresses and symposiums/Poster
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (07 December 2003). "Targeting of integrins with specific contrast agents for the in vitro and in vivo diagnostics of inflammatory pathologies by Magnetic Resonance Imaging" [Poster presentation]. Symposium on structure-based drug design, SRC, UCL, Louvain-la-Neuve, Unknown/unspecified.
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (07 December 2003). "C-MLISA (Cellular Magnetic-Linked Immunosorbent Assay), une nouvelle apllication d'ELISA cellulaire pour l'imagerie de résonance magnétique" [Poster presentation]. SRC, Mons, Belgium.
  • Laumonier, C., Segers, J., Laurent, S., Burtea, C., Michel, A., Vander Elst, L., & Muller, R. (07 December 2003). "Ciblage de la phosphatidylsérine par phage display: synthèse d'un agent de contraste IRM spécifique de l'apoptose" [Poster presentation]. SRC, Mons, Belgium.
  • Laumonier, C., Segers, J., Burtea, C., Laurent, S., Michel, A., Vander Elst, L., & Muller, R. (07 December 2003). "MR imaging of apoptosis using a phage display designed contrast agent" [Poster presentation]. Symposium on structure-based drug design, SRC, UCL, Louvain-la-Neuve, Unknown/unspecified.
  • Burtea, C., Laurent, S., Lecocq, S., Vander Elst, L., Colet, J.-M., & Muller, R. (06 December 2003). "Importance des sucres à chaine ouverte sur la prolongation du temps de demi-vie des dérivés du Gd-DTPA" [Poster presentation]. 10ème Congrès du GRAMM, Angers, France.
  • Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 December 2003). "C-MLISA (Cellular Magnetic-Linked Immunosorbent Assay), a new application of cellular ELISA for MRI" [Poster presentation]. 20th Annual Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Rotterdam, Netherlands.
  • Laumonier, C., Segers, J., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (06 December 2003). "Targeting phosphatidylserine by phage display to image apoptosis" [Poster presentation]. New in vivo imaging modalities for molecular biology, cell biology and physiology, Conférences Jacques-Monod, Roscoff, France.
  • Boutry, S., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2003). "Targeting inflammation in MRI with a superparamagnetic contrast agent" [Poster presentation]. XVIIe journées franco-belges de pharmacochimie : de la conception à la réalisation en pharmacochimie, UCL, Bruxelles, Belgium.
  • Boutry, S., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2003). "Targeting inflammation in MRI with a superparamagnetic contrast agent" [Poster presentation]. New in vivo imaging modalities for molecular biology, cell biology and physiology, Conférences Jacques-Monod, Roscoff, France.
  • Laumonier, C., Segers, J., Burtea, C., Laurent, S., Vander Elst, L., & Muller, R. (01 January 2003). "Targeting phosphatidylserine by phage display to image apoptosis" [Poster presentation]. XVIIe journées franco-belges de pharmacochimie : de la conception à la réalisation en pharmacochimie, UCL, Bruxelles, Belgium.
Top
2002
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Burtea, C., Boutry, S., Laurent, S., & Muller, R. (06 December 2002). "E-selectin targeting, a new strategy for inflammation imaging" [Paper presentation]. 'New Developments in Contrast Agent Research', 8th Bi-annual Conference on MR and Intermodality Contrast Agent Research, Budapest, Hungary.
  • Burtea, C., Laurent, S., Lecocq, S., Vander Elst, L., & Muller, R. (22 August 2002). "Synthesis and evaluation of some new glycosylated derivatives of Gd-DTPA as MRI blood pool contrast agents" [Paper presentation]. 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France.
  • Burtea, C., Laurent, S., & Muller, R. (22 August 2002). "A VLA-4 targeted contrast agent for the MRI labeling of mononuclear cells in inflammatory pathologies" [Paper presentation]. 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France.
  • Boutry, S., Burtea, C., Laurent, S., & Muller, R. (22 August 2002). "Development of a superparamagnetic contrast agent specific for inflammation" [Paper presentation]. 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France.
  • Laumonier, C., Segers, J., Burtea, C., & Muller, R. (22 August 2002). "Identification of a peptidic high affinity for phosphatidylserine to target apoptosis by MRI" [Paper presentation]. 19th Annual Scientific Meeting of the European Society of Magnetic Resonance in Medicine and Biology, Cannes, France.
Top
2001
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Vander Elst, L., Laurent, S., Burtea, C., Fu, Y., & Muller, R. (04 December 2001). "Sugar derivatives of lanthanide complexes, MRI contrast agents of increased specificity" [Paper presentation]. Contrast Media Research (CMR 2001), Capri, Italy.
  • Muller, R., Vander Elst, L., Laurent, S., Colet, J.-M., Fu, Y., Segers, J., Burtea, C., Boutry, S., & Laumonier, C. (04 December 2001). "New trends in the development of MRI contrast media" [Paper presentation]. 10 th International Conference on Bioinorganic Chemistry, ICBIC 10, Florence, Italy.
Top
2000
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Burtea, C., Laurent, S., Vander Elst, L., Roch, A., Sinnaeve, G., Baeten, V., & Muller, R. (04 December 2000). "1H and 13C NMR investigations on cocoa butter authenticity" [Paper presentation]. 1H and 13C NMR investigations on cocoa butter authenticity, Lednice, Czechia.
Top
1998
Scientific journals/Article
  • Dumitru, I., Burtea, C., Balta, N., Stoian, G., Mekhalfia, A., & Petec, G. (19 November 1998). An assay on blood, heart and liver biochemical markers in myocardial hypertrophy induced by isoproterenol. "Romanian Biotechnological Letters, 3" (3), 221-236.
  • Burtea, C., Gatina, R., Stoian, G., Mardare, M., Dumitru, I., & Dragomir, C. (03 November 1998). Spin-spin relaxation times in myocardial hypertrophy induced by endocrine agents in rat. "Magnetic Resonance Materials in Biology, Physics and Medicine, 7", 184-198. doi:10.1007/BF02591336
  • Burtea, C., Stoian, G., Mekhalfia, A., Balta, N., & Dumitru, I. (15 October 1998). Metabolic alterations in rat myocardium and liver after treatment with high doses of ACTH and isoproterenol. "Journal of Medicine and Biochemistry, 3" (1), 35-51.
  • Gatina, R., Balta, N., Moisin, C., Burtea, C., Botea, S., Ioan, M., & Teleianu, C. (10 July 1998). Research on red cell membrane permeability in arterial hypertension. "Romanian Journal of Physiology: Physiological Sciences, 35" (3-4), 285-302.
  • Dumitru, I., Burtea, C., Stoian, G., Mardare, M., Mekhalfia, A., & Balta, N. (15 June 1998). Tissue water alterations in rat liver and myocardium exposed to ACTH and isoproterenol treatment. A relaxometric study. "Journal of Medicine and Biochemistry, 2" (3), 237-249.
  • Miscalencu, D., Dumitru, I., Mailat, F., Burtea, C., Ivanciuc, L., & Barbu, E. (11 June 1998). Ultrastructural changes induced by isoproterenol and ACTH in hepatocytes and heart myocytes. "Journal of Medicine and Biochemistry, 2" (4), 353-359.
  • Dumitru, I., Burtea, C., Stoian, G., Mardare, M., Mekhalfia, A., & Balta, N. (1998). Modulation of the enzymes involved in rat liver glutathione metabolism by high doses of ACTH and isoproterenol. "Journal of Medicine and Biochemistry".
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Burtea, C., Gatina, R., Mardare, M., Stoian, G., Dumitru, I., & Dragomir, C. (17 September 1998). "1H-NMR investigations on water permeability of rat erythrocytes in endocrine induced myocardial hypertrophy" [Paper presentation]. 15th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Geneva, Switzerland.
  • Burtea, C., Mardare, M., Stoian, G., Mihalache, D., Dumitru, I., & Dragomir, C. (23 August 1998). "The T2 evolution in myocardial tissue depending on pH, KCl concentration and alteration of contractile protein thiol in physiological and pathological conditions" [Paper presentation]. 15th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Geneva, Switzerland.
Top
1997
Scientific journals/Book review
  • Dumitru, I., Balta, N., Burtea, C., Stoian, G., Mekhalfia, A., & Petec, G. (19 November 1997). Cardioprotective effect of fosfobion and thiamin in isoproterenol-induced myocardial hypertrophy. "Journal of Medicine and Biochemistry, 1" (4), 273-290.
Scientific journals/Article
  • Balta, N., Stoian, G., Boca, A., Burtea, C., Petec, G., Moisin, C., Teleianu, C., & Dumitru, I. (17 November 1997). Biochemical and histo-enzymological investigations of the myocardium and coronary system in assessing experimental cardiac hypertrophy. "Journal of Medicine and Biochemistry, 1" (3), 161-182.
  • Burtea, C., Mihalache, D., & Ungureanu, B. (20 May 1997). Precocious signals detected by 1H-NMR in rat liver exposed to oncogenic stress, interfering with fat-soluble vitamins D3 and E. "Libri Oncologici: Croatian Journal of Oncology, 26" (1), 19-24.
  • Burtea, C., Balta, N., Stoian, G., Petec, G., & Dumitru, I. (12 April 1997). A 1H-NMR study on the modulator effect of retinoic acid in the alcoholic intoxication. The identification of tissue water injuries induced by ethanol on liver and myocardium. "Journal of Medicine and Biochemistry, 1" (1), 25-36.
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Mihalache, D., Burtea, C., Ungureanu, B., & Mateescu, C. (18 September 1997). "Cellular water alterations in rat liver exposed to oncogenic stress. A relaxometric study" [Paper presentation]. 14th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Brussels, Belgium.
  • Burtea, C., Mateescu, C., Mardare, M., Stoian, G., Botea, S., & Mihalache, D. (18 September 1997). "1H-NMR in detection of the specific tissue injuries induced by hormones with cardiopathic potential" [Paper presentation]. 14th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Brussels, Belgium.
  • Burtea, C., & Mateescu, C. (18 September 1997). "The usefulness of 1H and 23Na NMR spectrometry in the study of muscle contraction and of myopathic alteration. An approach of the influence of proteins and ions on T2 in muscle tissue" [Paper presentation]. 14th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Brussels, Belgium.
Top
1996
Scientific journals/Article
  • Dumitru, I., Balta, N., Burtea, C., Stoian, G., & Petec, G. (16 May 1996). The protective role of thiamine associated with medicinal products based on biogenic amines and the metabolic modifications made evident by 1H-NMR. "Romanian Biotechnological Letters, 1" (3), 171-180.
Scientific congresses and symposiums/Unpublished conference/Abstract
  • Mocanu, M., Burtea, C., Gatina, R., & Botea, S. (18 September 1996). "1H-NMR measurements as a useful tool for detection of moderate changes on the myofilaments due to a subletal oxidative stress" [Paper presentation]. 13th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Prague, Unknown/unspecified.
  • Burtea, C., Mocanu, M., Mardare, M., Gatina, R., & Botea, S. (01 May 1996). "1H-NMR technique in detection of testosterone involvement in the risk of myocardial infarction and the role of tocopherol in protection" [Paper presentation]. 13th Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology, Prague, Unknown/unspecified.
Top
1995
Scientific journals/Article
  • Burtea, C., Gatina, R., Dinischiotu, A., Mocanu, M., & Nastasescu, G. (17 November 1995). Studies on the steroid hormones involvement in the muscular fatigue phenomena. "Studii şi Cercetări de Biochimie, 38" (1-2), 11-18.
  • Burtea, C., Gatina, R., Vasilescu, A., & Nastasescu, G. (11 November 1995). NMR and radioizotope studies concerning the steroid hormones influence over the contractile proteins of skeletal muscle. "Studii şi Cercetări de Biochimie, 38" (1-2), 3-10.
  • Botea, S., Burtea, C., & Mocanu, M. (07 April 1995). The influence of oestradiol treatment upon the protection conferred by preconditioning in ischaemic rat myocardium in vitro. "Romanian Journal of Endocrinology, 33" (3-4), 49-55.
  • Burtea, C., Gatina, R., Mocanu, M., Dinischiotu, A., & Nastasescu, G. (07 April 1995). Catecholamines and Ca2+ involvement in potentiating the resistance to physical effort induced by anabolic steroids. Sex-related differences. "Romanian Journal of Endocrinology, 33" (1-4), 31-39.
Top
1993
Scientific journals/Article
  • Burtea, C., Gatina, R., Lefter, C., David, A., Nastasescu, G., & Butnaru, F. (15 October 1993). The role of cathecolamines in muscle growth. "Romanian Journal of Endocrinology, 31" (3-4), 115-122.
  • Burtea, C., David, A., & Butnaru, F. (10 April 1993). The role of catecholamines in the distribution of steroid hormones in the striated and cardiac muscle. "Romanian Journal of Endocrinology, 31" (1-2), 41-48.
Top
1992
Scientific journals/Article
  • Burtea, C., Lefter, C., Butnaru, F., & David, A. (20 October 1992). Steroid hormones control on nucleic acid biosynthesis in skeletal muscle. "Romanian Journal of Endocrinology, 30" (3-4), 109-114.
  • Burtea, C., Murgiuc, C., David, A., & Dragomir, C. (25 September 1992). Influence of sex and glucocorticoid hormones on 3H-cholesterol uptake in the aortic wall and 3H-adrenaline in the brain. "Romanian Journal of Endocrinology, 29" (3-4), 137-145.
Top